Evidence map›Paper›PMID 27169879›Full record

ReviewThe Korean journal of internal medicine2016

Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.

Kyoung-Woon Kim, Hae-Rim Kim

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in The Korean journal of internal medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04315818 (The Relation Between Macrophage Migration Inhibitory Factor), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04315818 unknown statusnot on this mapstarted 2021, after this paper: background citation

The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis

TypeobservationalSponsorAssiut UniversityRan2021 to 2023Enrolled70ConditionsRheumatoid Arthritis
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Anti-inflammatory activity of different isolated sites ofExperimental and therapeutic medicine · 2021
    Article
  13. Review
  14. Correlations ofThe Journal of international medical research · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Altered Macrophage and Dendritic Cell Response inJournal of diabetes research · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kyoung-Woon KimConvergent Research Consortium for Immunologic Disease, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Hae-Rim KimDivision of Rheumatology, Department of Internal Medicine, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
Catholic University of Korea · KRKonkuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage migration inhibitory factor (MIF) is originally identified in the culture medium of activated T lymphocytes as a soluble factor that inhibits the random migration of macrophages. MIF is now recognized as a multipotent cytokine involved in the regulation of immune and inf lammatory responses. In rheumatoid arthritis (RA), MIF promotes inf lammatory responses by inducing proinflammatory cytokines and tissue-degrading molecules, promoting the proliferation and survival of synovial fibroblasts, stimulating neutrophil chemotaxis, and regulating angiogenesis and osteoclast differentiation. Expression of MIF in synovial tissue and synovial fluid levels of MIF are elevated in RA patients. Specifically, MIF levels correlate with RA disease activity and high levels are associated with bone erosion. In animal models of RA, the genetic and therapeutic inhibition of MIF has been shown to control inflammation and bone destruction. Based on the role of MIF in RA pathogenesis, small molecular inhibitors targeting it or its receptor pathways could provide a new therapeutic option for RA patients.

Indexed as

Molecular Targeted TherapyAnimalsAntirheumatic AgentsArthritis, RheumatoidDisease Models, AnimalHumansInflammation MediatorsIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsSignal TransductionAntirheumatic AgentsInflammation MediatorsIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humanArthritis, rheumatoidInflammationMacrophage migration-inhibitory factorsSmall molecular inhibitor

Identifiers

PMID27169879
PMCPMC4939511
OpenAlexW2370489452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.